Cargando...
On the mechanism of anti-CD39 immune checkpoint therapy
With the coming of age of cancer immunotherapy, the search for new therapeutic targets has led to the identification of immunosuppressive adenosine as an important regulator of antitumor immunity. This resulted in the development of selective inhibitors targeting various components of the adenosiner...
Gardado en:
| Publicado en: | J Immunother Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7057429/ https://ncbi.nlm.nih.gov/pubmed/32098829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000186 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|